Nobivac® Rabies
Owners wishing to take their dogs, cats and ferrets abroad to qualifying countries under the Pets Travel Scheme must ensure they are microchipped, and vaccinated against rabies at least 3 weeks before travel and be accompanied by a Pet Passport. For further information on the conditions and requirements of the pet travel scheme as well as a list of qualifying countries please visit the DEFRA webpages on this topic.
Presentation
Suspension for injection
Active ingredients
Nobivac Rabies is an inactivated vaccine containing > 2 I.U. Rabies virus strain Pasteur RIV per dose. Also contains Aluminium phosphate as an adjuvant and also 0.1 ml Thiomersal as a preservative.
Target species
Cat, dog
Indications for use
Nobivac Rabies is indicated for the active immunisation against rabies to reduce clinical signs and mortality. Limited safety data for ferrets are available from monitoring post vaccination reactions.
Ferrets can be vaccinated subcutaneously from 12 weeks of age.
An adequate serological response (≥ 0.5 I.U.) has been demonstrated 1 month after vaccination
and they should receive a booster vaccination every 18 months.
Packaging
APET-plastic tray box with 1 or 10 glass type I vials with 1 ml, with a rubber stopper and aluminium cap.
Legal category
POM-V
For full information please refer to the product data sheet. Further information is available on request.
Use Medicines Responsibly. For more information please refer to the Responsible Use sections of the NOAH website.
If you are not the prescribing veterinary surgeon, advice should be sought from the medicine prescriber.
Date of preparation: January 2018
